Research Article
Aucubin Promotes Osteogenic Differentiation and Facilitates Bone Formation through the lncRNA-H19 Driven Wnt/β-Catenin Signaling Regulatory Axis
Figure 4
Aucubin facilitated bone fracture healing in vivo. The femoral fracture was created in C57BL/6J mice and subsequently treated with Aucubin for 4 or 6 weeks of low-dose (0.5 mg/kg), high-dose (1.0 mg/kg), or stroke-physiological saline solution. (a) Representative X-ray images were taken during the fracture healing processes at weeks 4 and 6. (b, c) Micro-CT examination of the femur fractured zone in Aucubin-treated groups. (d) The statistical diagram of TV and BV/TV at weeks 4 and 6. n = 3. and .
(a) |
(b) |
(c) |
(d) |